Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Amortizatization of Intangibles: 2010-2025

Historic Amortizatization of Intangibles for Ironwood Pharmaceuticals (IRWD) over the last 10 years, with Sep 2025 value amounting to $426,000.

  • Ironwood Pharmaceuticals' Amortizatization of Intangibles rose 8.40% to $426,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 28.90%. This contributed to the annual value of $8.1 million for FY2018, which is 30.53% up from last year.
  • Ironwood Pharmaceuticals' Amortizatization of Intangibles amounted to $426,000 in Q3 2025, which was up 1.91% from $418,000 recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $426,000 during Q3 2025, with a 5-year trough of $378,000 in Q1 2024.
  • For the 2-year period, Ironwood Pharmaceuticals' Amortizatization of Intangibles averaged around $401,500, with its median value being $401,000 (2024).
  • Data for Ironwood Pharmaceuticals' Amortizatization of Intangibles shows a peak YoY increased of 8.57% (in 2025) over the last 5 years.
  • Ironwood Pharmaceuticals' Amortizatization of Intangibles (Quarterly) stood at $393,000 in 2024, then grew by 8.40% to $426,000 in 2025.
  • Its last three reported values are $426,000 in Q3 2025, $418,000 for Q2 2025, and $409,000 during Q1 2025.